We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Big Night is an online food delivery service that partners with selected independent food vendors to deliver exceptional meals to customers at home, in their office or wherever they choose. The company asserts that 61% of non-millennials find delivery overall frustrating. Big Night aims to change this scenario. It has signed on ten notable restaurants and has ten more in the immediate pipeline. Onboarded restaurants include Two Lights, Luca, The Laughing Heart, Sager + Wilde, Royale, Levan, AngloThai, Legare and Mangal2. Over 4,000 people have ordered via Big Night since its launch. The company will use 25% of the investment for operations, 25% for marketing, and 50% to improve the Big Night platform.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,168
A grocery delivery service for customers to purchase goods from local stores via an app. Grocemania launched in August 2017 and has signed more than 20 local and independent stores and gained over 350 users. Income is generated from a flat delivery fee of £2.50, as well as a 10% Commission Fee from its partners. The company has generated more than £27,000 in online sales for local stores in the past 3 months.
days to go: Expired investment: £76,557
Just Add Wine is an easy way for home cooks to add the taste of red wine to their recipes without having to open a new bottle or go out and purchase a bottle. Just Add Wine comes concentrated in a small sachet and is the equivalent of adding a full glass to your dish. 
days to go: Expired investment: £119,970
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.   
days to go: Expired investment: £30,564
Two Drifters Distillery (TDD) is one of the very few British distilleries that makes rum from raw ingredients, rather than importing and flavouring it. It has worked with Climeworks Direct Air Capture technology to remove CO2 from its products. The company's technique won admirers leading to a boost in sales. Since its launch in 2019, TDD converted existing equipment to increase capacity from 80 bottles per week to an estimated 1800 per week. It has also secured contracts from prominent entities including John Lewis (national and online), Exeter Chiefs Rum and Virgin Wines. The company has an active social media community with 10,000+ followers and also conducts weekly distillery tours that see full attendance from its customers. TDD has also received press coverage from media houses including The BBC, The Telegraph and The Independent. It will use the investment to grow its sales and showcase its product at retail outlets, and bring to the masses sustainably-made British products.

Pitch Rated

40%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £286,340
Sauce of Nature are a fresh pesto brand free from additives and preservatives, being marketed as more than just a stir through pasta sauce but also to be drizzled over salad, as an accompaniment to meat, fish and vegetables or simply enjoyed on its own. They aim to be recognised nationally and internationally and are working on further products such as a vegan range. 
days to go: Expired investment: £36,140
Fruity Beauties have created Vit C fuelled ice pops to provide a fun and nutritious burst of life. Fruity Beauties have all natural flavours as they are naturally sweetened by grape juice and give you 100% of your daily Vitamin C. 
days to go: Expired investment: £21,852
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph